APS (Adaptor protein with PH and SH2 domains) initiates a PI 3-kinase independent pathway involved in insulin-stimulated glucose transport. We recently identified Enigma, a PDZ and LIM domain-containing protein, as a partner of APS and showed that APS/Enigma complex plays a critical role in actin cytoskeleton organization in fibroblastic cells. Since actin rearrangement is important for insulin-induced Glut 4 translocation, we studied the potential involvement of Enigma in insulininduced glucose transport in 3T3-L1 adipocytes. Enigma mRNA was expressed in differentiated adipocytes and APS and Enigma were co-localized with cortical actin. Expression of an APS mutant unable to bind Enigma increased the insulin-induced Glut 4 translocation to the plasma membrane. By contrast, overexpression of Enigma inhibited insulin-stimulated glucose transport and Glut 4 translocation without alterations in proximal insulin signaling. This inhibitory effect was prevented with the deletion of the LIM domains of Enigma. Using time-lapse fluorescent microscopy of GFPactin, we demonstrated that the overexpression of Enigma altered insulin-induced actin rearrangements, whereas the expression of Enigma without its LIM domains was without effect. A physiological link between increased expression of Enigma and an alteration in insulin-induced glucose uptake was suggested by the increase in Enigma mRNA expression in adipose tissue of diabetic obese patients. Taken together, these data strongly suggest that the interaction between APS and Enigma is involved in insulin-induced Glut 4 translocation by regulating cortical actin remodelling and raise the possibility that modification of APS/Enigma ratio could participate in the alteration of insulin-induced glucose uptake in adipose tissue.
ENIGMA INTERACTS WITH APS TO CONTROL INSULIN-INDUCED ACTIN CYTOSKELETON REMODELING AND GLUT 4 TRANSLOCATION
Romain
INTRODUCTION
Insulin signaling is required for normal glucose homeostasis. Binding of insulin to its receptor results in the phosphorylation of several intracellular substrates, including the insulin receptor substrate (IRS) family, Shc, and APS. IRS phosphorylation leads to the activation of the PI 3 kinase pathway that is critical for insulin-induced glucose transport and Glut 4 translocation. However, while necessary the PI 3-kinase pathway does not seem to be sufficient and recently, a new pathway, independent of PI 3-kinase activation, has been described (1) . This pathway requires tyrosine phosphorylation of the adaptor protein APS by the insulin receptor (2) . APS for "Adaptor Protein with PH and SH2 domains" is the last identified member of a conserved family of SH2 adaptor molecules including Lnk and SH2-B (3). All members of this family contain a C-terminal SH2 domain, a central PH domain, and a N-terminal proline-rich region. Lnk is involved in T-cell receptor activation while APS and SH2-B are involved in the signaling pathway of receptors for various growth factors including insulin and IGF-1. APS is highly expressed in insulin-responsive tissues, especially in adipocytes, and is the preferential target for the insulin receptor kinase in these cell types compared to SH2-B (3, 4) . APS associates with phosphotyrosine residues situated within the activation loop of the insulin receptor via its SH2 domain (4-6) and undergoes insulin-stimulated tyrosine phosphorylation on tyrosine 618 allowing it to bind Cbl in complex with CAP (7) . Once phosphorylated on tyrosine residues, Cbl recruits the adapter protein CrkII in a complex with C3G, a GDP to GTP exchange factor for TC10, a Rho-family GTPase that regulates Glut 4 trafficking (1) . Several data favor an important role of APS in Glut 4 translocation. Indeed, in 3T3-L1 adipocytes, expression of a Y618F mutant of APS that is not phosphorylated in response to insulin, or knock-down of APS protein expression by using siRNA strategy inhibits insulin-induced Glut 4 translocation and glucose transport (2, 8) . Studies of APS-deficient mice have led to contradictory results since one report describes an increase in whole body insulin sensitivity and insulin effect on glucose transport in adipocytes while a more recent study concludes that APS does not appear to modulate insulin regulation of glucose metabolism (9, 10) . Thus, in order to bring about gain of insight into function of this protein, we searched for new partners of APS and identified Enigma as an APS binding protein by yeast two-hybrid screening (11) .
Enigma belongs to a family of cytoplasmic proteins and structurally, contains one amino-terminal PDZ domain and one to three carboxy-terminal LIM domains. Both PDZ and LIM domains are protein-protein interacting modules and several LIM domain-containing proteins were found to be associated with the actin cytoskeleton, playing a role in signal transduction and organization of actin filaments during various cellular processes (12) (13) (14) . The LIM domains of Enigma bind to protein kinases while its PDZ domain was shown to interact with actin binding proteins such as ß-tropomyosin (13) (14) (15) . This family of proteins could be involved in targeting protein kinases to cytoskeleton elements. Our recent report showing that Enigma and APS are co-localized with F-actin in insulin-induced membrane ruffles (11) and the previous report that Enigma interacts directly with the insulin receptor (16) support a model in which APS/Enigma complex could be a link between insulin signaling and actin cytoskeleton.
Several studies have revealed the importance of actin cytoskeletal organization in the regulation of insulin-induced Glut 4 translocation (1, 17) and implicated the TC10 pathway in this process (1).
Since APS/Enigma complex is involved in actin organization (11) , this prompted us to study the potential role of Enigma in insulin-induced Glut 4 translocation in adipocytes.
In the present study, we showed that APS and Enigma were co-localized with cortical actin in 3T3-L1 adipocytes and we propose that Enigma could play a role in insulin-induced Glut 4 translocation by regulating cortical actin dynamics.
RESULTS

APS and Enigma are co-localized with cortical actin cytoskeleton in 3T3-L1 adipocytes
We wanted to determine whether Enigma was expressed in 3T3-L1 cells and was associated with APS and actin cytoskeleton. Using a cDNA probe encoding the full-length sequence of Enigma, we detected, by Northern blot analysis, a transcript of 2.4 kb in both 3T3-L1 fibroblasts and fully differentiated 3T3-L1 adipocytes (Fig.1) . Enigma mRNA expression was not markedly modified upon differentiation in adipocytes. By contrast, APS mRNA expression was up-regulated in differentiated 3T3-L1 adipocytes ( Fig.1) in agreement with previously published data (4).
To determine the localization of the two proteins, 3T3-L1 adipocytes were co-transfected with both HA-Enigma and Myc-APS cDNAs and the distribution of the two proteins was studied by immunofluoresence staining using anti-HA and anti-Myc antibodies respectively, followed by confocal microscopy (Fig. 2 , panels A-C). We used HA-tagged Enigma because no commercial antibody was available against Enigma and the antibody kindly provided by Dr. Gill (13) did not recognise the endogenous protein in immunofluorescence or immunoprecipitation studies. HA-Enigma was distributed at the plasma membrane and in intracellular compartments ( Fig. 2A) . Myc-APS was predominantly localized near the cell surface, as previously described (2) with lower levels detected in intracellular structures (Fig. 2B ). An overlay of APS and Enigma staining revealed that the two proteins co-localized mainly at the plasma membrane ( Fig. 2C ) with partial co-localization inside the cells. APS and Enigma were previously shown to be associated with F-actin in membrane ruffles (11) .
In 3T3-L1 adipocytes, F-actin is mainlycortical, underlying the plasma membrane with some F-actin is present in perinuclear region (1) . We next wanted to determine whether Enigma and APS were localized with F-actin. Myc-APS or HA-Enigma cDNAs was transiently transfected in 3T3-L1 adipocytes and F-actin structures were visualised following Texas-red phalloidin staining (Fig. 2 , panels D-I). Phalloidin staining indicated that F-actin was mainly organized as cortical actin distributed at the periphery of the cells with some F-actin in the perinuclear region (Fig. 2 , panels E, H). An overlay of both APS and Enigma staining with F-actin staining revealed a co-localization of APS and Enigma with cortical actin (Fig 2, panels F, I ).
The interaction between APS and Enigma is involved in Glut 4 translocation
APS is an essential component of the CAP/Cbl pathway in the control of insulin-induced glucose uptake (2) . Moreover, insulin-stimulated Glut 4 translocation in adipocytes is dependent upon cortical actin remodelling (17) . We investigated whether the interaction between Enigma and APS plays a role in insulin-induced Glut 4 translocation. 
Enigma overexpression blocks insulin-induced actin remodelling
Insulin stimulates cortical actin rearrangement in 3T3-L1 adipocytes that is necessary for Glut 4 translocation (17). Enigma family members have been shown to regulate actin dynamic (20) (21) (22) (23) , and
Enigma overexpression induces loss of stress fibers in fibroblasts (11) . The co-localization of Enigma with cortical actin in 3T3-L1 adipocytes suggests that it could play a role in actin remodeling.
Because cortical actin structures in adipocytes are not as pronounced as stress fibers in fibroblasts, it is difficult to detect changes in actin organization in adipocytes following fixation. Therefore, to determine whether Enigma expression can modulate insulin-induced actin rearrangement in vivo, we Taken together, these data suggest that Enigma could play a role in glucose transport by regulating the dynamic of actin cytoskeleton.
APS AND Enigma mRNAs expression in adipose tissue of obese type 2 diabetic patients
Based on the above results, we hypothesized that in insulin resistant states a change in the ratio between APS and Enigma could lead to the formation of non-productive complex leading to abnormal actin dynamic. To investigate this hypothesis, we measured APS and Enigma mRNAs expression by quantitative real-time PCR analysis in subcutaneous adipose tissue of patients with type 2 diabetes.
Despite a trend towards an increase, APS gene expression was not significantly modified (P = 0.085) in adipose tissue of obese type 2 diabetic patients compared to control subjects (Fig. 8) . By contrast, Enigma mRNA expression was 5 fold increased (P = 0.002) in adipose tissue of diabetic patients compared with control subjects (Fig. 8 ). These data indicate that the expression of APS and Enigma are differentially regulated in insulin resistant state.
DISCUSSION
We previously identified the LIM and PDZ domains containing protein Enigma as a partner of APS (11) . We recently demonstrated that the APS/Enigma complex is involved in actin organization in fibroblasts (11) . APS is required for insulin-induced activation of the Cbl/CAP/TC10 pathway that could be potentially involved in the regulation of actin cytoskeleton (2, 24) . Cell cytoskeleton plays an important role in vesicular trafficking and several reports strongly support a role of the actin cytoskeleton in insulin-induced Glut 4 translocation (1). In this study, we show that APS and Enigma co-localize with F-actin beneath the plasma membrane in 3T3-L1 adipocytes. These findings are in agreement with our previous report that Enigma binds to APS in fibroblasts and that the APS/Enigma complex co-localizes with F-actin. In fibroblasts or preadipocytes, F-actin is well known to form stress fibers, lamellipodia, and filipodia. However, in differentiated 3T3-L1 adipocytes, F-actin forms cortical actin that is lining the inner face of the plasma membrane (1). Thus, it is likely that the APS/Enigma complex is co-localized with cortical actin in adipocytes. A role of Enigma could thus be to target adaptor proteins or growth factor receptors to cytoskeleton allowing the regulation of cell signaling. For instance, Enigma interacts with the Ret/ptc2 via its LIM2 domain and this interaction is required for mitogenic signaling probably by targeting Ret/ptc2 to cytoskeletal elements beneath the plasma membrane (14, 25) . In agreement with such a role, we found that the expression of an APS mutant unable to bind Enigma increased insulin-induced Glut 4 translocation while overexpression of Enigma alone markedly decreased both insulin-induced Glut 4 translocation and glucose uptake suggesting that the interaction between Enigma and APS could be involved in the regulation of this important metabolic effect of insulin. Interestingly, using real-time imaging techniques, we show that the expression of Enigma altered actin organization with the formation actin clusters and markedly reduced insulin-induced actin remodeling. A similar effect of Enigma on actin dynamic was reported in fibroblasts (11) . Indeed, in fibroblastic cell lines, the expression of Enigma induced dramatic alteration in actin cytoskeleton morphology with loss of stress fibers and the appearance of F-actin clusters. Furthermore, in cells that overexpress RIL or FHL3, two other LIM-domain containing proteins, F-actin dynamics are markedly altered suggesting that such a phenotype could be common to several LIM domain-containing proteins (22, 26) .
De novo actin polymerization may play an important role in insulin-dependent Glut 4 translocation since latrunculin, which prevents actin polymerization, has an inhibitory effect on Glut 4 translocation (17, 27, 28) . Moreover, jasplakinolide markedly increases actin polymerization at both cortical and perinuclear location and inhibits insulin-induced actin dynamics and Glut 4 translocation (17). The involvement of actin dynamics in Glut 4 translocation is also suggested by the observation that unconventional myosin Myo1C is required for Glut 4 trafficking in response to insulin (29) . Thus, the inhibition of insulin-induced actin remodeling induced by Enigma could explain its inhibitory effect on insulin-induced Glut 4-containing vesicles translocation to the plasma membrane. Actin cytoskeleton has been proposed to be necessary for several steps in insulin-induced glucose uptake. Indeed, the maintenance of Glut 4 storage compartment and the activation of signaling proteins involved in Glut 4 translocation are dependent on an intact actin structures (17, 27, 28, 30) .
Furthermore, insulin might modulate the cortical actin cytoskeleton in adipocytes to allow the tethering of Glut 4 vesicles to the plasma membrane before their docking and fusion (1, 31) . Finally, it has been shown that insulin stimulated the formation of actin comet tails on Glut 4-containing vesicles that are necessary for the efficient Glut 4 translocation from its storage compartment to the plasma membrane (32) . It is unlikely that inhibition of insulin signaling could explain the inhibitory effect of Enigma. Indeed, insulin-induced tyrosine phosphorylation of IRS1 and activation of PKB are not altered in Enigma-expressing cells. However, we cannot exclude that Enigma expression alters the activation of the TC10 signalling pathway but disruption of F-actin was shown to be without effect on insulin-induced Cbl tyrosine phosphorylation (17) . It is also unlikely that the inhibitory effect of
Enigma is due to a disruption of Glut 4 sequestration compartments since both in control adipocytes and in adipocytes that express Enigma, Glut 4 is mainly localized in a perinuclear compartment that has been shown to correspond to its intracellular sequestration compartment. Thus, one possible explanation is that Enigma by inhibiting insulin-induced actin remodeling could alter the tethering of Glut 4-containing vesicles with the plasma membrane. While F-actin content in adipocytes from APS-deficient mice (9) has not been measured, the increase in insulin effect could be in favor of a modified cortical actin organization that facilitates insulininduced Glut 4 insertion in the plasma membrane.
In conclusion, our study identifies Enigma as a partner of APS that is involved in F-actin dynamics in 3T3-L1 adipocytes and implies the interaction between APS and Enigma in the regulation of Glut 4 translocation in response to insulin. Thus, APS would act as a scaffolding protein that allows for the communication between different partners involved in the regulation of actin cytoskeleton
organization. An imbalance between the amounts of these proteins can alter insulin-induced actin remodeling and lead to a decrease in glucose transport. Enigma ∆LIM1/2/3 and Myc-APS[APTA] constructs were generated as described (11) . Full length APS and Enigma cDNA sequences as well as sequences encoding for various mutated forms were amplified by PCR and subcloned in pEGFP-C1 or pDsRed-C1 (BD biosciences Clontech, Palo Alto, CA, USA). The plasmid DNAs were purified using Qiagen purification kit (QIAGEN SA, Courtaboeuf, France).
MATERIALS AND METHODS
Materials
Physical and clinical characteristics of the study population
Six women and one man severely obese diabetic patients (age 45 ± 6 years, BMI 45 ± 8 kg/m2) were included in the present study. All patients were recruited through the department of surgery and liver transplantation where they were consulting for an elective bariatric surgery of their obesity. Diabetes was diagnosed before the bariatric surgery program (fasting plasma glucose >7mmol/l or previously known diabetes). Before surgery, fasting blood samples were obtained and used for determination of glycemia (8 ± 3 mmol/L) and insulinemia (11 ± 6 mIU/L) (37) . In addition, subcutaneous adipose tissue from 7 lean women (age 51 ± 10 years, BMI 22 ± 1 kg/m2), obtained while undergoing lipectomy for cosmetic purpose, was used as control adipose tissue (provided by Drs Alessi and Casanova, Marseille, France). During surgery, a surgical biopsy of subcutaneous adipose tissues was collected. Samples of the biopsies were immediately frozen in liquid nitrogen and stored at -80°C.
The experimental protocol was performed according to French legislation regarding Ethic and Human
Research (Huriet-Serusclat law, DGS 2003/0395). Informed consent was obtained from all obese subjects as well as from lean subjects.
Cell Culture
3T3-L1 fibroblasts were grown in 35 or 100-mm dishes in DMEM, 25 mM glucose, 10 % calf serum and induced to differentiate in adipocytes as described previously (38) . Briefly, 2 days after confluence, medium was changed for DMEM, 25 mM glucose, 10 % Fetal Calf Serum (FCS) supplemented with isobutylmethylxanthine (0.25 mM), dexamethasone (0.25 mM), TZD (10 µM) and insulin (5 µg/ml). The medium was removed after 2 days and replaced with DMEM, 25 mM glucose, 10 % FCS supplemented with insulin for two other days. The cells were then fed every two days with DMEM, 25 mM glucose, 10% FCS. 3T3-L1 adipocytes were used 8-15 days after the beginning of the differentiation protocol. Sixteen hours before each experiment, the medium was changed to serum-free DMEM supplemented with 0.5 % bovine serum albumin (BSA).
Northern Blot
Northern blot analysis was performed on poly(A)+ RNA prepared from either 3T3-L1 fibroblasts or adipocytes. A [α-32 P]dCTP-labeled probe corresponding to the coding sequences of APS or Enigma was generated by random priming and hybridization was performed overnight at 60°C in 15 % formamide, 1 % BSA, 0.5 M sodium phosphate (pH 7.2), 7% SDS, 100 µM EDTA, and 50 µg/ml denatured salmon sperm DNA and washed at a high stringency.
3T3-L1 Adipocytes Transfection and Glut 4 Translocation Assay
3T3-L1 adipocytes were transfected using a low voltage electroporation technique as described washed twice with ice-cold PBS and cover slips were mounted in Mowiol onto glass slides. Cells were examined using a Leica confocal microscope equipped with a Leica confocal laser scanning imaging.
Cells were studied using a PL APO 63 X 1.40 oil immersion objective. Series of images were collected along the z-axis and examined by sequential excitation at 488 nm (FITC), 568 nm (Texas Red), and 647 nm (Cy5). Each experiment was repeated at least three times. The images were then analyzed using PHOTOSHOP ® software (Adobe ® Systems, Mountain View, CA).
2-Deoxyglucose Uptake
3T3-L1 adipocytes were transfected by electroporation with 400 µg of plasmids and plated on 12-well plates coated with collagen IV and allowed to recover for 20 h (39, 40). Thereafter, cells were serumstarved in DMEM supplemented with 0.1 % fetal bovine serum for 2 h. Cells were then washed with Krebs-Ringer phosphate buffer (10 mM phosphate buffer, pH 7.4, 1 mM MgSO 4 , 1 mM CaCl 2 , 136 mM NaCl, 4.7 mM KCl) and incubated without or with insulin (100 nM) for 20 min in Krebs-Ringer phosphate buffer supplemented with 0.1 % bovine serum albumin. Glucose transport was determined by the addition of 2-[ 3 H]deoxyglucose (0.1 mM, 0.5 µCi/ml) as described previously (41). The reaction was stopped after 3 min by aspiration, and cells were washed four times with ice-cold PBS.
Cells were lysed in Krebs-Ringer phosphate, 1% Triton X-100, and glucose uptake was assessed by scintillation counting. Results were normalized for protein amount that was measured by BCA assay.
Immunoprecipitation and Immunoblot Analysis
Immunoprecipitation was performed as described (38) . Cells were washed with ice-cold buffer (20 mM Tris, pH 7.4, 150 mM NaCl, 5 mM EDTA) before solubilisation for 30 min at 4 C in lysis buffer (20 mM Tris, pH 7.4, 150 mM NaCl, 5 mM EDTA, protease inhibitors, and 1 % Triton X-100).
Following centrifugation at 15 000 x g for 15 min at 4 C, cell lysates were incubated for 3 h at 4 C with 4 µg of appropriate antibodies pre-adsorbed on protein G-Sepharose. The beads were washed twice with high-salt buffer (20 mM Tris, pH 7.4, 500 mM NaCl, 5 mM EDTA, protease inhibitors, and 1% Triton X-100), and once with lysis buffer. Immune pellets were boiled for 5 min in Laemmli buffer. Proteins were resolved by SDS-PAGE using 7.5 or 10% gels and were transferred to PVDF membrane. The membrane was blocked with saline buffer (10 mM Tris, pH 7.4, 140 mM NaCl) containing 5% (w/v) BSA and 0.1 % Nonidet-P40 for 2 h at room temperature, and was incubated overnight at 4 C with the indicated antibody. Following incubation with horseradish peroxidaseconjugated secondary antibodies, proteins were detected by enhanced chemiluminescence. required for the fluorescence to reach a threshold limit was determined in duplicate for each sample.
Time-lapse Microscopy
The relative amounts of the different mRNAs were quantified by using the second derivative maximum method. RPLP0 was used as an invariant control, and the relative quantification for a given gene was corrected to RPLP0 mRNA values. The results were expressed relative to the control condition, which was arbitrary assigned a value of 1. For each target an efficiency of the PCR method between 95 and 100%, a reproducibility of Ct values with a standard error less than 3% and a linear range of covering more at least 7 log units were obtained. Amplification of specific transcripts was confirmed by melting curve profiles generated at the end of each run.
Pre -designed primers were from Applied Biosystem with the following assay ID:
RPLP0:Hs99999902_m1; APS:Hs00184134_m1; Enigma:hs00193775_m1.
Statistical Analysis
All data are presented as means + SEM. This is a representation of insulin-stimulated time course of GFP-actin observed in three individual experiments.
Fig.8. Enigma mRNA expression is increased in adipose tissue of diabetic patients
Total RNA was extracted from subscutaneous adipose tissue biopsies from control (empty bars) of obese and diabetic patients (black bars) and the amount of APS and Enigma mRNAs was quantified by real-time quantitiative PCR . mRNA expression was normalized using RPLP0 RNA levels. Results are the means + SEM of n=7 for each group. *, P = 0.002; ns, non significant. 
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